spacer
home > pmps > winter 2017 > out with the old
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Out With the Old

What a year 2016 has been. The Year of the Monkey certainly lived up to the mischievous nature of the animal with 2016 having been possibly the most unpredictable year in living memory. If someone had placed a £1 bet a year ago on Leicester City winning the Premier League, the UK voting to leave the EU and Donald Trump being elected as the next president of the US, then they would have picked up £4.5 million from the bookmaker!

What Will 2017 Bring?

The next year is sure to see the repercussions of Brexit continuing to cause unrest within the pharma industry. The nature of the relationship between Britain and the EU will not be decided in 2017, but investment strategies will most definitely be influenced by the inevitability of changes to business and regulatory practices between the two and, of course, the question over the freedom of movement of workers within the EU.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Robert Harris is Chief Technical Officer at Juniper Pharma Services and PMPS Industry Advisor
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with their new integration

Philadelphia, PA – November 14, 2019: Signant Health, formerly CRF Health and Bracket, is proud to announce that it has integrated its industry leading eCOA platform TrialMax®, with ActiGraph’s CentrePoint system. The integration, which includes ActiGraph’s FDA 510(k) cleared sensors, helps simplify the process of collecting and monitoring real-world activity, mobility, and sleep outcomes data for patients and researchers.
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement